Table 2a.
Variation in Utilities based on EQ-5D at Baseline Survey
| Demographic | Patients with EQ-5D N (%) | EQ-5D Utilities Mean (SD) | EQ-5D Utilities Median (IQR) |
|---|---|---|---|
| All | 2396 (100%) | 0.78 (0.18) | 0.82 (0.15) |
| Sex | |||
| Male | 1242 (51.84%) | 0.78 (0.17) | 0.82 (0.15) |
| Female | 1154 (48.16%) | 0.77 (0.18) | 0.81 (0.15) |
| p-value* | n.s | ||
| Race/Ethnicity | |||
| Caucasian | 1788 (74.62%) | 0.79 (0.17) | 0.82 (0.15) |
| Latino | 107 (4.47%) | 0.76 (0.19) | 0.80 (0.26) |
| African American | 286 (11.94%) | 0.75 (0.19) | 0.80 (0.17) |
| Asian | 80 (3.34%) | 0.83 (0.17) | 0.81 (0.23) |
| Other | 135 (5.63%) | 0.74 (0.22) | 0.80 (0.15) |
| Missing | 0 (0%) | ||
| p-value† | p=0.0012 | ||
| Age | |||
| <=54 | 353 (14.73%) | 0.72 (0.21) | 0.78 (0.25) |
| 55-59 | 305 (12.73%) | 0.77 (0.17) | 0.81 (0.14) |
| 60-64 | 359 (14.98%) | 0.78 (0.17) | 0.81 (0.14) |
| 65-69 | 410 (17.11%) | 0.80 (0.18) | 0.82 (0.29) |
| 70-74 | 403 (16.82%) | 0.79 (0.18) | 0.83 (0.11) |
| 75-79 | 323 (13.48%) | 0.79 (0.16) | 0.82 (0.15) |
| 80+ | 243 (10.14%) | 0.82 (0.15) | 0.84 (0.08) |
| Missing | 0 (0%) | ||
| p-value† | <0.0001 | ||
| Stage at Diagnosis | |||
| I | 750 (31.30%) | 0.81 (0.17) | 0.83 (0.23) |
| II | 232 (9.68%) | 0.77 (0.17) | 0.81 (0.14) |
| III | 649 (27.09%) | 0.77 (0.18) | 0.81 (0.15) |
| IV | 628 (26.21%) | 0.76 (0.19) | 0.81 (0.15) |
| Unknown/Missing | 137 (5.72%) | 0.76 (0.19) | 0.81 (0.17) |
| p-value† | <0.0001 | ||
| Histology | |||
| NSCLC | 2025 (84.52%) | 0.78 (0.17) | 0.82 (0.15) |
| SCLC | 264 (11.02%) | 0.76 (0.19) | 0.82 (0.15) |
| Missing | 107 (4.53%) | 0.74 (0.22) | 0.81 (0.25) |
| p-value† | n.s. | ||
| Treatment | |||
| Surgery | 563 (23.50%) | 0.81 (0.16) | 0.83 (0.24) |
| Chemotherapy | 360 (15.03%) | 0.79 (0.19) | 0.82 (0.15) |
| Radiotherapy | 126 (5.26%) | 0.75 (0.19) | 0.81 (0.16) |
| Surgery w/Chemotherapy | 271 (11.31 %) | 0.79 (0.16) | 0.82 (0.08) |
| Surgery w/Radiotherapy | 63 (2.63%) | 0.72 (0.20) | 0.78 (0.27) |
| Chemoradiotherapy | 679 (28.34%) | 0.77 (0.18) | 0.81 (0.15) |
| Surgery w/Chemo/Rad | 207 (8.64%) | 0.76 (0.19) | 0.80 (0.14) |
| No Treatment | 127 (5.30%) | 0.79 (0.17) | 0.82 (0.11) |
| p-value† | <0.0001 | ||
| Comorbidity | |||
| None | 413 (17.24%) | 0.79 (0.17) | 0.82 (0.09) |
| Mild | 744 (31.05%) | 0.78 (0.18) | 0.82 (0.15) |
| Moderate | 412 (17.20%) | 0.77 (0.18) | 0.81 (0.14) |
| Severe | 375 (15.65%) | 0.78 (0.18) | 0.82 (0.15) |
| Unknown/Missing | 452 (18.86%) | 0.78 (0.18) | 0.82 (0.15) |
| p-value† | n.s. |
*
Mann-Whitney U test
†
Kruskal-Wallis test